ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237538 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237538; 2) Community: the network communities that were significantly associated with the response to NSC 237538; 3) Molecule: the relationships between components within communities and NSC 237538; 4) MDR: the compounds that were significantly associated with the NSC 237538.

NSC Compound Enrichment Correlation
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.00701295499506023 0.24155979
NSC 750873 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.00701295499506023 0.13768398
NSC 294734 7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- 0.00714731931708452 0.0091234769
NSC 645351 [Bis(aminomethyl)diethylsilane]dichloroplatinum (II) 0.00714731931708452 0.31441328
NSC 724602 S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate 0.00714731931708452 0.29948165
NSC 610457 Camptothecin Derivative 0.00770426557728506 0.7068083
NSC 640084 Null 0.00770426557728506 -0.12647135
NSC 648114 ANTINEOPLASTIC-D648114 0.00770426557728506 0.43891367
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.00770426557728506 0.46629896
NSC 671169 Null 0.00770426557728506 0.1954613
Total:60  Current:11    [First] [Prev] [Next] [Last]